Kymera Therapeutics Funding: $3B Raised, Series C (2020)

Kymera Therapeutics funding overview

Kymera Therapeutics is based in Watertown, Massachusetts. Kymera Therapeutics has raised $3B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is a Series C announced in March 2020. The round record for Kymera Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Biotechnology Value Fund, Redmile Group, Wellington Management Company, Bain Capital Life Sciences, Janus Henderson Investors, BlackRock and 2 others. 8 distinct backers are named across the disclosed rounds.

Kymera Therapeutics at a glance

Total raised: $3B
Latest round: Series C
Latest round date: March 2020
Headquarters: Watertown, Massachusetts
Notable investors: Biotechnology Value Fund, Redmile Group, Wellington Management Company, Bain Capital Life Sciences, Janus Henderson Investors, BlackRock, Rock Springs Capital, The Leukemia & Lymphoma Society‘s Therapy Acceleration Prog…

Frequently asked about Kymera Therapeutics funding

How much has Kymera Therapeutics raised?: Kymera Therapeutics has raised $3B in total disclosed funding across the rounds on record.
Who has invested in Kymera Therapeutics?: Biotechnology Value Fund, Redmile Group, Wellington Management Company, Bain Capital Life Sciences, Janus Henderson Investors, BlackRock are named among the investors backing Kymera Therapeutics.
What was the latest Kymera Therapeutics funding round?: The most recent disclosed round is a Series C, announced in March 2020.
Where is Kymera Therapeutics based?: Kymera Therapeutics is based in Watertown, Massachusetts.
When did Kymera Therapeutics last raise?: The last disclosed Kymera Therapeutics round closed in March 2020 at Series C.

Kymera Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Watertown below to benchmark round size and investor mix.

Kymera Therapeutics Funding: $3B Raised, Series C (2020)

Kymera Therapeutics funding overview

Kymera Therapeutics at a glance

Frequently asked about Kymera Therapeutics funding

Companies related to Kymera Therapeutics (18)

Browse related funding lists (7)